Reports
Sale
Global Cardiac Pacemaker Market Share, Analysis, Forecast: By Product Type: MRI Compatible Pacemaker, Conventional Pacemaker, Implantable Pacemakers, External Pacemakers; By Technology: Single Chamber Pacemaker, Dual Chamber Pacemaker, Others; By Applications; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Cardiac Pacemaker Market Outlook
The global cardiac pacemaker market size attained a value of about USD 4.91 billion in 2023. The market is further expected to grow at a CAGR of 4.3% to attain a value of USD 7.10 billion by 2032. The growth of the market can be attributed to the increasing prevalence of heart rhythm disorders, such as bradycardia and heart block.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Demand in Ambulatory Surgical Centres to Augment the Cardiac Pacemaker Industry Growth
Based on end use, ambulatory surgical centres account for a significant share in the cardiac pacemaker industry. This can be attributed to its advanced consumer penetration and ease of care, especially in rural areas. In this case, ambulatory surgical centres have also proved to be a competent option. In addition, some of the high-impact market drivers for ambulatory surgical centres are projected to be the growing demand for reducing surgical and post-surgical spending and increasing prevalence of cardiovascular diseases.
The Asia-Pacific Region to Provide Enhanced Growth Opportunities to the Cardiac Pacemaker Industry
Region-wise, the Asia Pacific is expected to witness a robust growth over the forecast period owing to the increasing cases of cardiovascular disorders in the region. The growth is driven by the market expansion by major players and the presence of significant untapped opportunities. In addition, investment in the healthcare sector has gained momentum, especially in Japan, India, and China. These countries are increasingly focused on building comprehensive heart diagnostic and recovery healthcare facilities. These variables are anticipated to contribute to the market growth in the coming years.
Cardiac Pacemaker: Market Segmentation
A pacemaker is a tiny instrument in your chest that is mounted under the skin to help stabilize your heartbeat. It is used if you have an erratic heartbeat (arrhythmia), especially a sluggish one, to make the heartbeat more consistent. It takes a surgical operation to insert a pacemaker in your chest. After a heart attack, surgery, or drug overdose, they may be inserted temporarily to treat a sluggish pulse. Or, they may be permanently inserted to correct a sluggish or erratic pulse or to help treat cardiac disease in certain individuals.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By type, the market is divided into:
- Implantable
- External
Based on technology, the market is categorised into:
- Biventricular
- Single Chambered
- Dual Chambered
- Others
Based on application, the market is divided into:
- Arrhythmias
- Congestive Heart Failure
- Others
On the basis of end use, the market is segmented into:
- Hospitals and Clinics
- Ambulatory Surgery Centres
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Prevalence of Cardiovascular Diseases to Bolster the Growth of the Cardiac Pacemaker Industry
With the rise in people suffering from cardiovascular diseases, the cardiac pacemaker industry is at an all-time high. Citizens all over the world have adopted a sedentary lifestyle, which is leading to obesity, diabetes, and other lifestyle disorders. These lifestyle disorders turn into serious cardiovascular diseases such as high blood pressure, heart attack, and arrhythmia. The rise in poor lifestyle, combined with the technological advancements in the sector is likely to increase the demand for cardiac pacemaker. This is aiding the growth of the overall market. Further, the reimbursement policies offered by the government has impacted the industry in a positive way. However, lack of understanding of cardiovascular diseases among the population in developed countries and the high medical costs may hamper the market growth.
Over the forecast period, rise in demand for advanced diagnostic facilities and the rapid technological advancements are expected to favour the industry growth. The worldwide increase in the sedentary population is expected to be a major trend in the coming years.
Key Industry Players in the Global Cardiac Pacemaker Market
The report gives a detailed analysis of the following key players in the global cardiac pacemaker market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Zoll Medical Corporation
- MicroPort Scientific Corporation
- OSCOR Inc.
- Osypka Medical GmbH
- Medtronic
- Abbott
- Boston Scientific Corporation
- BIOTRONIK
- LivaNova
- Pacetronix
- MEDICO
- Osypka Medical
- Lepu Medical Co ltd.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Technology |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cardiac Pacemaker Market Overview
3.1 Global Cardiac Pacemaker Market Historical Value (2017-2023)
3.2 Global Cardiac Pacemaker Market Forecast Value (2024-2032)
4 Global Cardiac Pacemaker Market Landscape
4.1 Global Cardiac Pacemaker Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cardiac Pacemaker Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
4.2.4 Analysis by End User
5 Global Cardiac Pacemaker Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cardiac Pacemaker Market Segmentation
6.1 Global Cardiac Pacemaker Market by Product Type
6.1.1 Market Overview
6.1.2 MRI Compatible Pacemaker
6.1.3 Conventional Pacemaker
6.1.4 Implantable Pacemakers
6.1.5 External Pacemakers
6.2 Global Cardiac Pacemaker Market by Technology
6.2.1 Market Overview
6.2.2 Single Chamber Pacemaker
6.2.3 Dual Chamber Pacemaker
6.2.4 Biventricular/CRT Pacemaker
6.3 Global Cardiac Pacemaker Market by Applications
6.3.1 Market Overview
6.3.2 Arrhythmia
6.3.3 Atrial Fibrillation
6.3.4 Bradycardia
6.3.5 Tachycardia
6.3.6 Others
6.4 Global Cardiac Pacemaker Market by End User
6.4.1 Market Overview
6.4.2 Cardiac Centres
6.4.3 Ambulatory surgical Centres
6.4.4 Hospitals
6.4.5 Clinics
6.4.6 Others
6.5 Global Cardiac Pacemaker Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Cardiac Pacemaker Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cardiac Pacemaker Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cardiac Pacemaker Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cardiac Pacemaker Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cardiac Pacemaker Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Zoll Medical Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 MicroPort Scientific Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 OSCOR Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Osypka Medical GmbH
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Medtronic
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Abbott
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Boston Scientific Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 BIOTRONIK
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 LivaNova
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Pacetronix
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 MEDICO
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Osypka Medical
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Lepu Medical Co ltd.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Cardiac Pacemaker Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2023, the global cardiac pacemaker market was aided by the growing pacemaker market which attained a volume of nearly 1.32 million units.
The pacemaker market is projected to grow at a CAGR of 2% between 2024 and 2032 thereby aiding the growth of the cardiac pacemaker market.
The major drivers of the market include the rise in poor lifestyle, combined with the technological advancements, reimbursement policies offered by the government, rise in demand for advanced diagnostic facilities, increasing focus on building comprehensive heart diagnostic and recovery healthcare facilities, and worldwide increase in the sedentary population.
The rise in people suffering from cardiovascular diseases and the rise in lifestyle disorders like diabetes due to sedentary lifestyle are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The types of cardiac pacemakers are implantable and external.
Based on technology, the market is categorised into biventricular, single chambered, and dual chambered, among others.
Based on application, the market is classified into arrhythmias and congestive heart failure, among others.
On the basis of end-use, the market is segmented into hospitals and clinics and ambulatory surgery centres, among others.
The major players in the industry are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Shree Pacetronix Ltd., and Medico S.p.A., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER